fluorodeoxyglucose f18 has been researched along with Sarcoma in 297 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 16 (5.39) | 18.2507 |
| 2000's | 99 (33.33) | 29.6817 |
| 2010's | 140 (47.14) | 24.3611 |
| 2020's | 42 (14.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, M; Chen, Y; Liu, J; Wei, W; Zhao, X | 1 |
| Bechtel, S; Bryan, JN; Collins, A; Flesner, B; Henry, C; Lunceford, J; Maitz, CA; Saha, S; Tate, D; Tung, D; Varterasian, M; Zhang, L | 1 |
| Aparisi Gómez, MP; Bazzocchi, A; Fanti, S; Farina, A; Gasperini, C; Nanni, C | 1 |
| Batus, M; Blank, AT; Colman, MW; Gitelis, S; Kazmer, A; Lee, L | 2 |
| Cheng, C; Dong, A; Yang, Q; Zhang, Z; Zuo, C | 1 |
| Akdemir, ÜÖ; Atay, LÖ; Aydos, U; Karadeniz, C; Okur, A; Pinarli, FG; Poyraz, A; Sever, T; Topuz Türkcan, B; Vural, Ö | 1 |
| Agrawal, A; Bakshi, G; Joshi, A; Kale, SA; Menon, S; Murthy, V; Prakash, G; Purandare, N; Puranik, A; Rangarajan, V; Shah, S | 1 |
| He, Q; Jiang, S; Liu, Z; Zhang, L; Zhang, R | 1 |
| Chen, J; He, Y; Li, C; Tian, Y; Wen, B | 1 |
| Chan, LWC; Chiu, KWH; Jiang, L; Qiu, J; Wei, X; Yuan, H; Zhang, F | 1 |
| Karakousis, GC; Sharon, CE; Straker, RJ | 1 |
| Gu, J; Guo, W; He, F; Ji, T; Li, Y; Liu, R; Shen, D; Sun, K; Sun, X; Xie, L; Xu, J | 1 |
| Mendoza, H; Nosov, A; Pandit-Taskar, N | 1 |
| Bahri, H; Bouhamama, A; Brahmi, M; Corradini, N; Delattre, O; Guinot, A; Isnardi, V; Lapouble, E; Marec-Bérard, P; Pierron, G; Surdez, D; Tabone-Eglinger, S; Villemeur, M | 1 |
| Kessler, L | 1 |
| Cui, F; Hou, W; Li, L; Li, Q; Ma, B; Ren, Y; Su, M; Sun, X; Tian, R; Wu, M; Xu, J; Zou, K | 1 |
| Chen, H; Dai, J; Gao, F; Tian, R | 1 |
| Chen, Q; Dong, A; Guo, J; Huang, M; Liao, Z | 1 |
| Albertson, ME; Chandra, SR; Hansen, NJ; Johnson, CM; Rodriguez-Vazquez, JR | 1 |
| Abu-Hijleh, HA; Abualruz, A; Aldahamsheh, OO; Thalib, L; Younis, MH | 1 |
| Liu, Y | 2 |
| Abdalah, MA; Aerts, HJWL; Andrearczyk, V; Apte, A; Ashrafinia, S; Bakas, S; Beukinga, RJ; Boellaard, R; Bogowicz, M; Boldrini, L; Buvat, I; Cook, GJR; Davatzikos, C; Depeursinge, A; Desseroit, MC; Dinapoli, N; Dinh, CV; Echegaray, S; El Naqa, I; Fedorov, AY; Gatta, R; Gillies, RJ; Goh, V; Götz, M; Guckenberger, M; Ha, SM; Hatt, M; Isensee, F; Lambin, P; Leger, S; Leijenaar, RTH; Lenkowicz, J; Lippert, F; Löck, S; Losnegård, A; Maier-Hein, KH; Morin, O; Müller, H; Napel, S; Nioche, C; Orlhac, F; Pati, S; Pfaehler, EAG; Rahmim, A; Rao, AUK; Richter, C; Scherer, J; Siddique, MM; Sijtsema, NM; Socarras Fernandez, J; Spezi, E; Steenbakkers, RJHM; Tanadini-Lang, S; Thorwarth, D; Troost, EGC; Upadhaya, T; Valentini, V; Vallières, M; van Dijk, LV; van Griethuysen, J; van Velden, FHP; Whybra, P; Zwanenburg, A | 1 |
| Albert, A; Janssen, N; Verheyen, J | 1 |
| Hou, W; Li, Q; Su, M; Tian, R | 1 |
| Deng, J; Guo, S; Kong, W; Shi, Y; Zeng, W | 1 |
| Itagaki, K; Kurotaki, H; Masuda, S; Naganuma, M; Nagaya, K; Suzuki, N | 1 |
| Errani, C; Mavrogenis, AF; Tanaka, Y; Tsukamoto, S | 1 |
| Chen, B; Feng, H; Li, C; Wang, S; Xie, J; Zhang, Y | 1 |
| Shen, G; Tian, R; Wang, R | 1 |
| Kunz, WG; Rejeski, K; Ricke, J; Rudelius, M; Ruzicka, M; Schmidt, C; Subklewe, M; Unterrainer, M; Winkelmann, M | 1 |
| Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Chen, X; Huang, Y; Jiang, Y; Luo, R; Wang, F | 1 |
| Browning, MB; Kumbhar, SS; Qi, J; Thakrar, PD; Vo, N | 1 |
| Bastidas, JF; Bronte, Á; García, L; García-Velloso, MJ; Rosales Castillo, JJ | 1 |
| Chen, X; Chen, ZK; Pan, B; Wang, SC | 1 |
| Bonnefoy, PB; Cornillon, J; Flandrin, P; Jacquet-Francillon, N; Prevot, N; Rigollet, L; Tavernier, E | 1 |
| Akagi, M; Hashimoto, K; Nishimura, S | 1 |
| Beets-Tan, R; Bodalal, Z; Bruining, A; Colombo, P; Gennaro, N; Haas, R; Messiou, C; Reijers, S; van der Graaf, WTA; van Houdt, W | 1 |
| Chen, P; Jiang, M; Zheng, J; Zhou, W | 1 |
| Benz, MR; Crompton, JG; Harder, D | 1 |
| Bisogno, G; Cameron, A; Chisholm, J; Coppadoro, B; Corradini, N; Gallego, S; Jehanno, N; Mercolini, F; Merks, JH; Minard-Colin, V; Rogers, T; Scarzello, G; Van Rijn, RR; Zucchetta, P | 1 |
| Bauer, S; Erfanian, Y; Forsting, M; Grueneisen, J; Herrmann, K; Kirchner, J; Podleska, LE; Poeppel, T; Umutlu, L; Wetter, A | 1 |
| Honda, H; Hong, S; Kamei, R; Kawanami, S; Matsumoto, Y; Sagiyama, K; Watanabe, Y | 1 |
| Chang, CP; Huang, WS; Lee, TH; Wu, YH | 1 |
| Fujino, K; Kaneda, H; Kimura, M; Kusunoki, S; Ota, T; Takeda, S; Terao, Y; Ujihira, T | 1 |
| Davidson, DJ; Elojeimy, S; Favinger, JL; Ha, AS; Hippe, DS; Lindberg, AW; Roth, ES | 1 |
| Daldrup-Link, HE; Gulaka, PK; Muehe, AM; Pareek, A; Spunt, SL; Theruvath, AJ | 1 |
| Dobrenić, M; Hmelik, S; Huić, D | 1 |
| Cohen-Levy, WB; Greif, DN; Jose, J; Pretell-Mazzini, J; Singer, AD; Subhawong, T | 1 |
| Asanuma, K; Hagi, T; Matsubara, T; Nakamura, T; Sudo, A; Sugino, Y | 1 |
| Huang, Y; Jiang, L; Wang, H; Wu, X; Zhang, C | 1 |
| Hao, CY; Li, ZW; Liu, DN; Wang, HY; Zhao, M; Zhao, W | 1 |
| Freeman, CR; Jung, S; Levesque, IR; Turcotte, R; Xing, S | 1 |
| Hirata, K; Kitao, T; Sekizawa, M; Shiga, T; Takei, T; Tamaki, N; Yamashiro, K | 1 |
| Gholamrezanezhad, A; Jadvar, H; Katal, S; Kessler, M; Olyaei, M | 1 |
| Goni, V; Kumar, R; Mittal, BR; Parihar, AS; Sood, A; Vadi, SK | 1 |
| Ding, C; Lai, R | 1 |
| Hirata, K; Iyama, Y; Kidoh, M; Nagayama, Y; Nakagawa, M; Nakaura, T; Namimoto, T; Oda, S; Sakamoto, F; Shiraishi, S; Yamashita, Y | 1 |
| Tammisetti, VS; Thampy, R; Thupili, CR | 1 |
| Alberti, N; Buy, X; Crombé, A; Kind, M; Le Loarer, F; Pilleul, F; Villard, N | 1 |
| DE Geus-Oei, LF; Desar, IME; Grootjans, W; Koenen, AM; Oyen, WJ; Steeghs, N; VAN DER Graaf, WT; VAN Erp, NP; Verheijen, RB; Vlenterie, M | 1 |
| Bianchi, G; Donati, DM; Errani, C; Fanti, S; Longhi, A; Nanni, C; Righi, A; Sambri, A | 1 |
| Kiyono, Y; Kurokawa, T; Mori, T; Okazawa, H; Yoshida, Y; Zhao, Z | 1 |
| Choi, JH; Jung, TE; Lee, DH; Lee, JH; Park, WJ; Shin, DG | 1 |
| Cabral, FC; Jagannathan, JP; Kim, KW; Krajewski, KM; Ramaiya, NH | 1 |
| Arens, A; de Geus-Oei, LF; Gotthardt, M | 1 |
| Cardillo, G; Graziano, P; Treglia, G | 1 |
| Andreou, A; Fisher, C; MacVicar, D; Sohaib, A; Whitten, C | 1 |
| Hickeson, M; Holcroft, C; Makis, W; Nahal, A; Rakheja, R; Skamene, S; Tulbah, R; Turcotte, R | 1 |
| Choi, ES; Ha, JH; Ha, SG; Han, I; Kim, HS; Paeng, JC | 1 |
| Bengel, F; Fegbeutel, C; Länger, F; Meyer, B; Rodt, T; von Falck, C; Wacker, F | 1 |
| Giovanella, L; Hasanzadeh, M; Kadkhodayan, S; Sadeghi, R; Treglia, G; Zakavi, SR | 1 |
| Bruland, Ø; Malinen, E; Rusten, E; Rødal, J | 1 |
| Chadaz, T; Hobbs, SK; Son, H | 1 |
| Baron, N; Charbonnel, C; Convers-Domart, R; Deleuze, P; Georges, JL; Livarek, B; Pesenti-Rossi, D | 1 |
| Charest, M; Dahlstrom, KR; Dalhstrom, KR; Freeman, C; Hickeson, M; Nahal, A; Rakheja, R; Roberge, D; Skamene, SR; Turcotte, R | 1 |
| Conrad, EU; Eary, JF; Hawkins, DS; O'Sullivan, F; O'Sullivan, J; Schuetze, SM | 1 |
| Bærentzen, S; Madsen, GA; Rasmussen, TR | 1 |
| Blay, JY; Combemale, P; Giammarile, F; Goulart, DM; Guillot, B; Mognetti, T; Pinson, S; Valeyrie-Allanore, L; Wolkenstein, P | 1 |
| Andreou, D; Boldt, H; Jobke, B; Pink, D; Reichardt, P; Schuler, M; Tunn, PU; Werner, M | 1 |
| Choi, JY; Choi, YL; Hong, SP; Koo, HH; Lee, SE; Seo, SW; Sung, KS | 1 |
| Avery, RJ; Davis, MA; Gimber, LH; Scalcione, LR; Taljanovic, MS; Thompson, RB | 1 |
| Fiore, MR; Fossati, P; Iannalfi, A; Orecchia, R; Tuan, J; Vischioni, B; Vitolo, V | 1 |
| Chen, YL; El Fakhri, G; Huang, C; Li, Q; Ouyang, J; Petibon, Y; Reese, TG; Syrkina, A | 1 |
| Barquin, E; Collins, B; Gardner, K; Judson, I; Jürgensmeier, JM; Leahy, M; Marotti, M; Scurr, M; Young, H | 1 |
| Asa, S; Halaç, M; Sager, S; Uslu, L | 1 |
| Le, BB; Nguyen, BD | 1 |
| Bongiovanni, M; Ceriani, L; Giovanella, L; Paone, G; Treglia, G | 1 |
| Choi, YY; Kim, JY; Lee, S; Paik, SS; Park, J | 1 |
| Chuman, H; Kato, Y; Kawai, A; Kobayashi, E; Kubota, D; Nakatani, F; Nishida, Y; Ogura, K; Setsu, N; Tanzawa, Y | 1 |
| Chalian, M; Fergus, N; Kosmas, C; Mansoori, B; Partovi, S; Robbin, MR; Ros, PR; Zipp, L | 1 |
| Gelfand, MJ; Sharp, SE; Trout, AT; Turpin, BK; Zhang, B | 1 |
| Liu, F; Liu, ML; Pastakia, B; Xu, F | 1 |
| Bartenstein, P; Chalkidis, RP; Cyran, CC; Fendler, WP; Hacker, M; Herrmann, K; Ilhan, H; Issels, RD; Knösel, T; Lindner, LH | 1 |
| Boellaard, R; Collette, S; Dewji, R; Hristova, I; Marreaud, S; Mottaghy, F; Oyen, WJ; Sanfilippo, R; Schöffski, P; van der Graaf, W; Vogel, W | 1 |
| Biswal, S; Gambhir, SS; Ganjoo, K; Iagaru, A; Jackson, T; Mittra, E; Mosci, C; von Eyben, R | 1 |
| Hafezi-Nejad, N; Marcus, C; Sheikhbahaei, S; Subramaniam, RM; Taghipour, M | 1 |
| El Naqa, I; Freeman, CR; Skamene, SR; Vallières, M | 1 |
| Andersen, KF; Fuglo, HM; Loft, A; Petersen, MM; Rasmussen, SH | 2 |
| Chen, YK; Chi, KH; Chi, MS; Chung, CH; Huang, SC; Ko, HL; Lee, CY; Liao, KW; Yang, KL | 1 |
| Guo, Y; Wang, T; Yang, M | 1 |
| Gabriel, M; Rubello, D | 1 |
| Clemmensen, AE; El Ali, HH; Hansen, AE; Kjær, A; Kristensen, AT; Oxboel, J; Zornhagen, KW | 1 |
| Chebib, IA; Chen, YL; El Fakhri, G; Huang, C; Lim, R; Zhang, X | 1 |
| Luo, QY; Qiu, ZL; Shen, CT; Song, HJ; Wei, WJ | 1 |
| Baik, SH; Jeon, TJ; Kang, J; Lee, JH; Lee, KY; Lim, BJ; Ryu, YH; Sohn, SK | 1 |
| Bochev, P; Chaushev, B; Dancheva, Z; Klisarova, A; Yordanova, T | 1 |
| Brugières, P; Djelbani-Ahmed, S; Itti, E; Luciani, A; Ortonne, N; Rahmouni, A; Sbidian, E; Valeyrie-Allanore, L; Van Der Gucht, A; Wolkenstein, P; Zehou, O | 1 |
| Furuta, T; Johan, MP; Kubo, T; Ochi, M | 1 |
| Agnew, J; Bennett, O; Ravi Kumar, AS | 1 |
| Dirlik Serim, B; Sonmezoglu, K; Vatankulu, B; Vatankulu, MA | 1 |
| He, L; Li, F; Li, J; Zhao, Q; Zhuang, X | 1 |
| Cheng, YS; Dai, YL; Li, YJ; Tu, CQ; Zhang, WB | 1 |
| Cheon, GJ; Chung, JK; Hong, SH; Kang, KW; Lee, DS; Lee, H; Paeng, JC; Yoo, HJ | 1 |
| Benisvy, D; Dufour, M; Gastaud, L; Iannessi, A; Kogay, M; Saada, E; Thariat, J; Thyss, A | 1 |
| Kollàr, A; Langer, R; Sachpekidis, C; Wartenberg, J | 1 |
| Dasgupta, R; Gelfand, MJ; Kremer, N; Nagarajan, R; Pressey, JG; Sharp, SE; Tiao, GM; Turpin, BK; Wagner, LM; Yin, J | 1 |
| Dry, SM; Eilber, FC; James, AW; Shurell, E; Singh, A | 1 |
| Ailawadhi, S; Gautam, A; Sahu, KK | 1 |
| Colletti, PM; Dubreuil, J; Giammarile, F; Glehen, O; Rousset, P; Rubello, D; Skanjeti, A | 1 |
| Dubreuil, J; Giammarile, F; Rubello, D; Skanjeti, A; Tordo, J | 1 |
| Dikici, S; Dirlik Serim, B; Halaç, M; Kantarcı, F; Sönmezoğlu, K; Vatankulu, B | 1 |
| Eary, JF; O'Sullivan, F; O'Sullivan, J; Wolsztynski, E | 1 |
| Bek, CS; Kim, HW; Song, BI; Won, KS | 1 |
| Chen, L; Guo, L; Li, Q; Ma, X; Wu, X; Zhu, C | 1 |
| Chino, Y; Kiyono, Y; Kurokawa, T; Mori, T; Okazawa, H; Shinagawa, A; Tsujikawa, T; Yamada, S; Yamamoto, M; Yoshida, Y | 1 |
| Charest, M; Derbekyan, V; Hickeson, M; Novales, JA; Singnurkar, A | 1 |
| Berrebi, O; Keller, A; Ratib, O; Rougemont, AL; Steiner, C | 1 |
| Chen, YJ; Lai, CR; Liu, RS; Shen, SH; Shieh, HJ; Sung, PL; Wang, PH; Wen, KC; Yen, MS; Yuan, CC | 1 |
| Arai, K; Hirahashi, M; Iwamoto, Y; Jono, O; Oya, M; Sakamoto, A | 1 |
| Almusa, O; Daly, B; Shreve, P | 1 |
| de Geus-Oei, LF; de Rooy, JW; Oyen, WJ; van de Luijtgaarden, AC; van der Graaf, WT | 1 |
| Conrad, EU; Eary, JF; O'Sullivan, F; O'Sullivan, J | 1 |
| Fujino, T; Harasawa, A; Mochizuki, K; Morii, T; Sano, H; Satomi, K | 1 |
| Al-Nahhas, A; Ambrosini, V; Castellucci, P; Cracco, E; Fanti, S; Grassetto, G; Lopci, E; Maffione, AM; Marzola, MC; Massaro, A; Musto, A; Nanni, C; Piva, M; Rampin, L; Rubello, D; Tsamita, CS | 1 |
| Benjamin, R; Fitzgerald, TJ; Scheutze, S; Shankar, LK; Van den Abbeele, A; Yap, J | 1 |
| Farsad, M; Osele, L; Pernter, P; Triani, A; Wiedermann, CJ | 1 |
| Chang, CH; Chang, CW; Chang, TJ; Chou, TK; Lin, WJ; Liu, RS; Wang, HE; Wang, SJ; Wu, CY | 1 |
| Allen-Auerbach, MS; Benz, MR; Chow, K; Czernin, J; Dry, SM; Eckardt, JJ; Eilber, FC; Elashoff, D; Evilevitch, V; Phelps, ME; Tap, WD; Weber, WA | 1 |
| Choe, W; Hwang, KH; Jeon, IS; Kim, JE; Kwon, CG; Lee, MK; Tchah, H | 1 |
| Abdel-Dayem, H; Libes, R; Lin, H; Mikhaeil, M; Mousavi, A; Piperkova, E; Rosen, G; Viejo-Rullan, F | 1 |
| Devic, S; Freeman, CR; Hickeson, M; Karam, I; Roberge, D; Turcotte, RE | 1 |
| Benz, MR; Czernin, J; Eilber, FC; Federman, N; Tap, WD; Tchekmedyian, N | 1 |
| Agarwal, M; Arora, A; Parasar, DS; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR | 1 |
| Inoue, T; Kubota, Y; Minamimoto, R; Tateishi, U; Uemira, H; Yamanaka, S | 1 |
| Charest, M; Derbekyan, V; Hickeson, M; Lisbona, R; Novales-Diaz, JA; Turcotte, RE | 1 |
| Endo, H; Hasuo, K; Ito, K; Kubota, K; Matsuda, H; Morooka, M; Shida, Y | 1 |
| Gamble, B; Ho, L; Meka, M | 1 |
| Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
| Landa, J; Schwartz, LH | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
| Choe, JG; Kang, CH; Kim, CH; Noh, W; Park, EK; Park, JH | 1 |
| Hickeson, M; Makis, W | 1 |
| Carrel, TP; Fischer Biner, R; Gugger, M; Krause, TM; Minder, S; Nicod, LP; Schmid, RA; Stoupis, C; Tueller, C; Vock, P | 1 |
| Li, L; Nagamatsu, A; Tanaka, T; Umesaki, N | 1 |
| Berger, F; Issels, R; Reiser, MF; Rist, C; Schlemmer, M; Schramm, N | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Schmitt, T; Strauss, LG; Vasamiliette, J | 1 |
| Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Kasper, B; Lehner, B; Mechtersheimer, G; Schmitt, T; Strauss, LG; Stroebel, P; Vasamiliette, J | 1 |
| Amthauer, H; Beck, JF; Bierbach, U; Denecke, T; Franzius, C; Furth, C; Hautzel, H; Henze, G; Hundsdörfer, P; Kluge, R; Misch, D; Otto, S; Plotkin, M; Ruf, J; Schönberger, S; Steffen, IG; Stöver, B | 1 |
| Akiyama, T; Choong, PF; Clark, JC; Miki, Y; Ngan, S | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Dry, SM; Eilber, FC; Elashoff, D; Phelps, ME; Tap, WD | 1 |
| Dua, SG; Purandare, NC; Rangarajan, V; Shah, S; Sharma, AR; Suryawanshi, PV | 1 |
| Kaji, Y; Kitajima, K; Murakami, K; Sugimura, K | 1 |
| Franzius, C | 1 |
| Iagaru, AH; Leung, AN; Mittra, ES | 1 |
| Dua, SG; Purandare, N; Rangarajan, V; Shah, S; Sharma, AR; Zade, AA | 1 |
| Aro, H; Böhling, T; Elomaa, I; Kallajoki, M; Kivioja, A; Lindholm, P; Mattila, K; Minn, H; Oikonen, V; Sutinen, E; Tarkkanen, M | 1 |
| Ceyssens, S; Stroobants, S | 1 |
| de Geus-Oei, LF; Oyen, WJ; Quak, E; van de Luijtgaarden, AC; van der Graaf, WT | 1 |
| Conrad, EU; Eary, JF; Krohn, KA; Link, JM; Mankoff, DA; Muzi, M; White, JK | 1 |
| Broaddus, VC; Feng, J; Gao, D; He, J; Iyer, AK; Lan, X; Liu, B; Seo, Y; Su, Y; Vanbrocklin, HF; Zhang, X; Zhu, X | 1 |
| Ersoy, H; Hsiao, E; Laury, A; Menard, MT; Rybicki, FJ | 1 |
| Arisaka, Y; Endo, K; Higuchi, T; Hirato, J; Ishikita, T; Miyashita, G; Oriuchi, N; Ote, EL; Paudyal, B | 1 |
| de Geus-Oei, LF; de Rooy, JW; Flucke, UE; Hambrock, T; Schreuder, BW; van de Luijtgaarden, AC; van der Geest, IC; Vriens, D | 1 |
| Borri, A; Brambilla, D; Casiraghi, M; Ciprandi, B; De Pas, T; Donghi, SM; Galetta, D; Gasparri, R; Guarize, J; Maisonneuve, P; Petrella, F; Solli, P; Spaggiari, L; Tessitore, A; Veronesi, G | 1 |
| Carpentier, P; Kolesnikov-Gauthier, H; Leblond, P; Rocourt, N | 1 |
| Kiyono, Y; Kotsuji, F; Kurokawa, T; Okazawa, H; Tsujikawa, T; Yoshida, Y | 1 |
| Chun, IK; Chung, JK; Eo, JS; Kim, DW; Lee, DS; Paeng, JC | 1 |
| Conrad, EU; Eary, JF; O'Sullivan, F; O'Sullivan, J; Richards, T; Wolsztynski, E | 1 |
| Arishima, Y; Komiya, S; Nagano, S; Tanimoto, A; Terahara, M; Yokouchi, M; Yoshioka, T; Zemmyo, M | 1 |
| Mi, B; Wan, W; Xu, Q; You, X; Yu, C | 1 |
| Allen-Auerbach, M; Apichairuk, W; Czernin, J; Federman, N; Nelson, S; Phelps, ME; Walter, F; Walter, MA | 1 |
| Benjamin, RS; Debnam, JM; Garden, AS; Ginsberg, LE; Guha-Thakurta, N; Mahfouz, YM; Sturgis, EM | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Dry, SM; Eilber, FC; Radu, C; Spick, C; Sutthiruangwong, P; Tap, WD; Weber, WA | 1 |
| Conrad, EU; Eary, JF | 2 |
| Bal, C; Jain, SK; Jeph, S; Kumar, R; Malhotra, A; Sharma, DN; Sharma, JB; Sharma, P; Singh, H | 1 |
| Choi, DJ; Chung, JH; Jheon, S; Lee, CT; Lee, JH; Lee, SW; Park, JS; Yoon, HI | 1 |
| Allen-Auerbach, M; Czernin, J; Dunkelmann, S; Federman, N; Hall, T; Walter, F; Walter, MA | 1 |
| Alford, S; Chander, S; Choong, P; Chu, J; Henderson, M; Ngan, S; Powell, G; Williams, S | 1 |
| Eirini, L; Emmanouil, L; Hans-Günther, M; Liodaki, E; Liodakis, E; Machens, HG; Nikolaos, PA; Othonas, P; Papadopoulos, O; Papadopulos, NA | 1 |
| Allen-Auerbach, MS; Benz, MR; Czernin, J; Dry, SM; Eckardt, JJ; Eilber, FC; Herrmann, K; Phelps, ME; Schuster, T; Tap, WD; Weber, WA | 1 |
| Henderson, R; Ho, L; Sheth, S; Wassef, H | 1 |
| Assayag, J; Azoulay, L; Brimo, F; Hickeson, M; Makis, W; Nahal, A; Rakheja, R; Skamene, S; Turcotte, R | 1 |
| Fuglø, HM; Hovgaard, D; Jørgensen, SM; Loft, A; Petersen, MM | 1 |
| Busk, M; Bussink, J; Engelholm, SA; Hansen, AE; Jørgensen, JT; Kjær, A; Kristensen, AT; McEvoy, FJ; van der Kogel, AJ | 1 |
| Chuman, H; Inoue, T; Kawai, A; Kim, EE; Miyake, M; Nakatani, F; Nishiyama, Y; Tateishi, U; Terauchi, T | 1 |
| Choe, YS; Choi, JY; Choi, YS; Kim, BT; Lee, EJ; Lee, KH; Lee, KS; Moon, SH | 1 |
| Gámez Cenzano, C; García del Muro, FJ; Narváez García, JA; Rodríguez Bel, L; Sabaté Llobera, A | 1 |
| Altieri, ML; Altini, C; Fanelli, M; Merenda, N; Niccoli-Asabella, A; Notaristefano, A; Rubini, G; Stabile-Ianora, AA | 1 |
| Betancourt, SL; Gutierrez, FR; Martinez-Jimenez, S; Restrepo, CS | 1 |
| Bruland, OS; Malinen, E; Revheim, ME; Rusten, E; Rødal, J; Skretting, A | 1 |
| Al-Ibraheem, A; Beer, AJ; Benz, MR; Buck, AK; Haller, B; Herrmann, K; Juenger, H; Mansour, A; Pomykala, KL; Rudert, M; Scheidhauer, K; Schwaiger, M | 1 |
| Nguyen, BD; Nguyen, VX | 1 |
| Berrocal, I; Canessa, J; Castro, G; Gallegos, I; Jofré, MJ; Massardo, T; Sierralta, MP | 1 |
| Bruckner, JD; Chandhury, KR; Conrad, EU; Eary, JF; O'Sullivan, F; Powitan, Y; Vernon, C | 1 |
| Bredella, MA; Caputo, GR; Steinbach, LS | 1 |
| Benatar, NA; Goodey, J; Marsden, PK; O'Doherty, MJ; Smith, MA; Somer, EJ | 1 |
| Alavi, A; Anderson, GS; Brinkmann, F; Soulen, MC; Zhuang, H | 1 |
| Frick, MP; Karabulut, N; Martin, DR; Yang, M | 1 |
| Conrad, EU; Eary, JF; Rubin, BP; Schuetze, S; Vernon, CB | 1 |
| Feldman, F; Manos, C; van Heertum, R | 1 |
| Ioannidis, JP; Lau, J | 1 |
| Bourguet, P | 1 |
| Ahmed, AR; Aoki, J; Endo, K; Shinozaki, T; Takagishi, K; Watanabe, H; Yanagawa, T | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Adler, LP; Israel-Mardirosian, N | 1 |
| Akhurst, T; Flores, RM; Gonen, M; Larson, SM; Rusch, VW | 1 |
| Antoch, G; Beyer, T; Bockisch, A; Debatin, JF; Freudenberg, LS; Görges, R | 1 |
| Eary, J; O'Sullivan, F; Roy, S | 1 |
| Buchmann, I; Gfrörer, W; Glatting, G; Kotzerke, J; Leithäuser, F; Möller, P; Reske, SN; Schulte, M; Schultheiss, S; Vogg, AT | 1 |
| Cole, P; Dimitrijevic, S; Dumez, H; Dupont, P; Goeminne, J; Martens, M; Mortelmans, L; Nuyts, J; Sciot, R; Seegers, M; Silberman, S; Stroobants, S; van den Borne, B; van Oosterom, A | 1 |
| Alavi, A; Chiang, SB; Johnson, GR; Khan, J; Zhuang, H | 1 |
| Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, M; Strauss, LG; Willeke, F | 1 |
| Bingham, J; Chinyama, C; Hain, SF; O'Doherty, MJ; Smith, MA | 1 |
| Bastiaannet, E; Cobben, DC; Groen, H; Hoekstra, HJ; Jager, PL; Vaalburg, W; van der Graaf, WT | 1 |
| Gietema, JA; Jager, PL; van der Graaf, WT | 1 |
| Allred, TJ; Anstadt, MP; Gossage, JR; Kallab, AM; Pancholy, A; Williams, HT | 1 |
| Bruckner, JD; Conrad, EU; Eary, JF; Hawkins, DS; Rubin, BP; Schuetze, SM; Vernon, C | 1 |
| Büchler, MW; Cardona, S; Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, MH; Strauss, LG; Willeke, F | 1 |
| Conrad, EU; Eary, JF; Morgan, HD; Schuetze, SM; Vernon, C | 1 |
| Graham, MM; Kubo, A; Nishitani, H; Otsuka, H | 1 |
| Eary, J; O'Sullivan, F; O'Sullivan, J; Roy, S; Vernon, C | 1 |
| Debus, V; Drees, G; Etz, C; Franzius, C; Hoffmeier, A; Kehl, HG; Löher, A; Maintz, D; Ozgun, M; Rothenburger, M; Scheld, HH; Schmid, C; Spieker, T; Tjan, TD | 1 |
| Franzius, C; Juergens, KU; Vormoor, J | 1 |
| Arai, Y; Hasegawa, T; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U | 1 |
| Weber, WA; Wieder, H | 1 |
| Bode, B; Exner, U; Lardinois, D; Strobel, K | 1 |
| Schuetze, SM | 1 |
| Basu, S; Nair, N | 1 |
| Chang, U; Cheon, GJ; Gwak, HS; Kim, HJ; Kim, K; Lee, DH; Rhee, CH; Youn, SM | 1 |
| Chauhan, A; Chawla, M; Kumar, R; Vellimana, AK | 1 |
| Chawla, S; Conti, PS; Iagaru, A; Menendez, L | 1 |
| Fulham, MJ; Mohamed, A; O' Neill, GF; Thambugala, GM | 1 |
| de Toledo, JS; Roca, I; Sábado, C; Simó, M | 1 |
| Arush, MW; Bar-Shalom, R; Israel, O; Meller, I; Militianu, D; Postovsky, S; Sapir, AE; Zaidman, I | 1 |
| Been, LB; Elsinga, PH; Hoekstra, HJ; Jager, PL; Suurmeijer, AJ; van Ginkel, RJ | 1 |
| Pomper, MG; Solomon, SB | 1 |
| Cho, EY; Chong, S; Kim, BT; Kim, J; Kim, TS | 1 |
| Klippenstein, DL; Lamonica, DM | 1 |
| Arai, Y; Hosono, A; Imai, Y; Kim, EE; Makimoto, A; Sakurada, A; Tateishi, U; Terauchi, T | 1 |
| Bensaid, B; Combemale, P; Drouet, A; Galoisy-Guibal, L; Giammarile, F; Mognetti, T; Pinson, S | 1 |
| Arai, Y; Kim, EE; Seki, K; Tateishi, U; Terauchi, T; Yamaguchi, U | 1 |
| Amthauer, H; Denecke, T; Furth, C; Hautzel, H; Henze, G; Misch, D; Plotkin, M; Ruf, J; Schönberger, S; Steffen, I; Stöver, B; Völker, T | 1 |
| Chang, CC; Chang, TT; Chen, YW; Chiu, SS; Huang, MY; Lee, CS; Liao, YM | 1 |
| Chawla, SP; Conti, PS; Fedenko, A; Iagaru, A; Masamed, R; Menendez, LR | 1 |
| Allen-Auerbach, M; Chow, K; Czernin, J; Eckardt, JJ; Eilber, FC; Eilber, FR; Elashoff, RM; Evilevitch, V; Nelson, SD; Phelps, ME; Tap, WD; Weber, WA | 1 |
| Peterson, JJ | 1 |
| Dietrich, S; Dimitrakopoulou-Strauss, A; Egerer, G; Haberkorn, U; Ho, AD; Kasper, B; Strauss, LG | 1 |
| Hicks, RJ; Toner, GC | 1 |
| Hoekstra, HJ; Koops, HS; Molenaar, WM; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
| Hoekstra, HJ; Koops, HS; Molenaar, WM; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ; Willemsen, AT | 1 |
| Larcos, G; Maisey, MN | 1 |
| Brizel, DM; Charles, HC; Coleman, RE; Dewhirst, MW; Friedman, HS; Harrelson, JM; Jones, DN; Layfield, L; McCowage, GB; Prescott, DM; Scully, SP; Sostman, HD | 1 |
| Garcia, R; Kim, EE; Korkmaz, M; Podoloff, DA; Wong, FC; Wong, WH; Yang, DJ | 1 |
| Hoekstra, HJ; Kole, AC; Koops, HS; Nieweg, OE; Paans, AM; Pruim, J; Vaalburg, W; van Ginkel, RJ | 1 |
| Adler, LP; Faulhaber, P; Miraldi, F | 1 |
| Eary, JF; Mankoff, DA | 1 |
| Bruckner, JD; Conrad, EU; Eary, JF; Folpe, A; Howlett, AT; Hunt, KJ; Mankoff, DA | 1 |
| Bingham, JB; Fletcher, CD; Lucas, JD; McKee, PH; O'Doherty, MJ; Smith, MA; Wong, JC | 1 |
| Al Suhaibani, H; Bakheet, SM; Ezzat, A; Powe, J; Rostom, A; Tulbah, A | 1 |
| Eary, JF; Graham, MM; Grierson, JR; Kozawa, SM; Krohn, KA; Lewellen, B; Lewellen, TK; Link, JM; Mankoff, DA; Shields, AF; Zheng, M | 1 |
| Cronin, BF; Lodge, MA; Lucas, JD; Marsden, PK; O'Doherty, MJ; Smith, MA | 1 |
| Cronin, BF; Lodge, MA; Lucas, JD; Marsden, PK; McKee, PH; O'Doherty, MJ; Smith, MA | 1 |
| Hain, SF; Lucas, JD; O'Doherty, MJ; Smith, MA | 1 |
| Attigah, N; Dimitrakopoulou-Strauss, A; Herfarth, C; Hinz, U; Lehnert, T; Mechtersheimer, G; Schwarzbach, MH; Strauss, LG; Willeke, F; Zhang, YM | 1 |
| Comans, EF; Dragoiescu, C; Hoekstra, OS; Van Riel, A | 1 |
| Conrad, EU; Eary, JF; Folpe, AL; Lyles, RH; Sprouse, JT | 1 |
| O'Doherty, MJ; Smith, MA | 1 |
| O'Doherty, MJ | 1 |
| Aoki, J; Endo, K; Inoue, T; Mohara, S; Sano, K; Shinozaki, T; Takagishi, K; Tokunaga, M; Watanabe, H; Yanagawa, T | 1 |
| Brecht-Krauss, D; Diederichs, CG; Guhlmann, A; Hartwig, E; Heymer, B; Kotzerke, J; Reske, SN; Sarkar, MR; Schulte, M; Von Baer, A | 1 |
| Abdel-Dayem, HM; el-Zeftawy, H; Heiba, SI; Jana, S; Rosen, G; Salem, S; Santiago, JF | 1 |
| Andersson, LC; Capdeville, R; Demetri, GD; Dimitrijevic, S; Druker, B; Joensuu, H; Roberts, PJ; Sarlomo-Rikala, M; Silberman, S; Tervahartiala, P; Tuveson, D | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Heichel, T; Lehnert, T; Mechtersheimer, G; Schwarzbach, M; Strauss, LG; Willeke, F | 1 |
| Draisma, A; Pauwels, EK; Stokkel, MP | 1 |
| Ben Arush, MW; Best, LA; Elhasid, R; Goralnik, L; Israel, O; Kedar, Z; Meushar, N; Postovsky, S | 1 |
| Aoki, J; Endo, K; Inoue, T; Shinozaki, T; Takagishi, K; Tomiyoshi, K; Watanabe, H | 1 |
| Koh, T; Kunishima, S; Taniguchi, H; Yamagishi, H; Yamaguchi, A | 1 |
| Haberkorn, U | 1 |
| Bockisch, A; Franzius, C; Hillmann, A; Jürgens, H; Schober, O; Schulte, M; Winkelmann, W | 1 |
| Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, ME; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Sonzogni, A; Spaggiari, L; Veronesi, G | 1 |
| Floresca, J; Graham, MM; Juweid, M; Malik, J; Menda, Y; Reddy, MP | 1 |
53 review(s) available for fluorodeoxyglucose f18 and Sarcoma
| Article | Year |
|---|---|
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma.
Topics: Adolescent; Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Young Adult | 2022 |
The Role of Imaging in Soft Tissue Sarcoma Diagnosis and Management.
Topics: Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2022 |
Molecular imaging of sarcomas with FDG PET.
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2023 |
Fibroblast Activation Protein Inhibitor (FAPI)-PET Imaging in Sarcoma.
Topics: Bone Neoplasms; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Osteosarcoma; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma | 2023 |
Meta-Analysis of the Diagnostic Accuracy of Primary Bone and Soft Tissue Sarcomas by 18F-FDG-PET.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2020 |
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
Primary pulmonary artery sarcoma with intrapulmonary metastases based on PET/CT imaging: a case report and literature review.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma | 2021 |
Imaging response evaluation after neoadjuvant treatment in soft tissue sarcomas: Where do we stand?
Topics: Fluorodeoxyglucose F18; Humans; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome | 2021 |
PET/CT Variants and Pitfalls in Bone and Soft Tissue Sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2021 |
PET in the Diagnostic Management of Soft Tissue Sarcomas of Musculoskeletal Origin.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Muscle Neoplasms; Neoplasm Staging; Neoplasms, Connective and Soft Tissue; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Treatment Outcome | 2018 |
Peritoneal lymphomatosis: CT and PET/CT findings and how to differentiate between carcinomatosis and sarcomatosis.
Topics: Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Lymphoma; Multimodal Imaging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
Imaging appearance of sarcomas of the prostate.
Topics: Adenocarcinoma; Bone Neoplasms; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.
Topics: Female; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Uterine Neoplasms | 2013 |
Radiation therapy for retroperitoneal sarcoma.
Topics: Chemotherapy, Adjuvant; Dose-Response Relationship, Radiation; Evidence-Based Medicine; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Leiomyosarcoma; Liposarcoma; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Retroperitoneal Neoplasms; Risk Assessment; Risk Factors; Sarcoma; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Magnetic resonance/positron emission tomography (MR/PET) oncologic applications: bone and soft tissue sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2014 |
Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Sarcoma; Tomography, X-Ray Computed | 2016 |
Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
Topics: Bone Neoplasms; Chi-Square Distribution; Fluorodeoxyglucose F18; Humans; Odds Ratio; Osteosarcoma; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Factors; Sarcoma; Soft Tissue Neoplasms; Survival Analysis | 2016 |
Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
Topics: Bone Neoplasms; Disease-Free Survival; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tumor Burden | 2016 |
Malignant Peripheral Nerve Sheath Tumor.
Topics: Fluorodeoxyglucose F18; Humans; Nerve Sheath Neoplasms; Neurilemmoma; Neurofibroma; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2016 |
18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
Topics: Carcinoma; Desmoplastic Small Round Cell Tumor; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphoma; Male; Mesothelioma; Ovarian Neoplasms; Peritoneal Neoplasms; Positron Emission Tomography Computed Tomography; Pseudomyxoma Peritonei; Radiopharmaceuticals; Sarcoma; Stomach Neoplasms | 2017 |
Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Uterine Neoplasms | 2017 |
Prognostic value of 18F-FDG PET-CT-based functional parameters in patients with soft tissue sarcoma: A meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Prognosis; Sarcoma; Soft Tissue Neoplasms | 2017 |
Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron-Emission Tomography; Sarcoma | 2008 |
Positron-emission tomography in gynaecologic malignancies.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity | 2009 |
Considerations for the use of imaging tools for phase II treatment trials in oncology.
Topics: Clinical Trials, Phase II as Topic; Endpoint Determination; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Neoplasms; Positron-Emission Tomography; Quality Assurance, Health Care; Sarcoma | 2009 |
Utilization of positron emission tomography in the management of patients with sarcoma.
Topics: Bone Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2009 |
Spectrum of FDG PET/CT findings of uterine tumors.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Positron-Emission Tomography; Precancerous Conditions; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Uterine Neoplasms | 2010 |
FDG-PET/CT in pediatric solid tumors.
Topics: Bone Neoplasms; Brain Neoplasms; Child; Fluorodeoxyglucose F18; Hepatoblastoma; Histiocytosis, Langerhans-Cell; Humans; Liver Neoplasms; Neoplasms; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2010 |
Sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2011 |
Clinical applications of positron emission tomography in sarcoma management.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2011 |
[Contribution of FDG-PET in the management of pediatric sarcomas in 2011].
Topics: Bone Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Organ Specificity; Osteosarcoma; Positron-Emission Tomography; Practice Guidelines as Topic; Prognosis; Radiopharmaceuticals; Sarcoma | 2011 |
PET scanning in plastic and reconstructive surgery.
Topics: Breast Neoplasms; Diabetic Foot; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Keloid; Male; Melanoma; Multimodal Imaging; Neoplasm Staging; Plastic Surgery Procedures; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Surgical Flaps; Tomography, X-Ray Computed | 2012 |
Tumors of the pulmonary artery and veins.
Topics: Contrast Media; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Veins; Radiographic Image Enhancement; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2012 |
[Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Young Adult | 2012 |
18F-FDG PET for the diagnosis and grading of soft-tissue sarcoma: a meta-analysis.
Topics: Fluorodeoxyglucose F18; Humans; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
[Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in sarcomas].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed; Treatment Outcome | 2003 |
FDG-PET for evaluating musculoskeletal tumors: a review.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography of soft tissue sarcomas.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Biopsy, Needle; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Staging; Randomized Controlled Trials as Topic; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Tomography, Emission-Computed | 2004 |
Monitoring chemotherapy and radiotherapy of solid tumors.
Topics: Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Lung Neoplasms; Monitoring, Physiologic; Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Uterine Cervical Neoplasms | 2006 |
Utility of positron emission tomography in sarcomas.
Topics: Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Sarcoma | 2006 |
Role of PET/PET-CT in the management of sarcomas.
Topics: Fibrosarcoma; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed | 2006 |
PET imaging: update on sarcomas.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2007 |
F-18 FDG-PET for detection of osseous metastatic disease and staging, restaging, and monitoring response to therapy of musculoskeletal tumors.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2007 |
PET for sarcomas other than gastrointestinal stromal tumors.
Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome | 2008 |
PET imaging in soft tissue sarcomas.
Topics: Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1997 |
PET in oncology I--lung, breast, soft tissue sarcoma.
Topics: Breast Neoplasms; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2000 |
Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Hepatocellular; Colorectal Neoplasms; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms; Outcome Assessment, Health Care; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Nuclear imaging of bone tumors: FDG-PET.
Topics: Bone Neoplasms; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2001 |
[The role of diagnostic PET in treatment planning before tumor surgery].
Topics: Breast Neoplasms; Carcinoma, Bronchogenic; Clinical Trials as Topic; Colorectal Neoplasms; Combined Modality Therapy; Diagnosis, Differential; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasms; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thyroid Neoplasms; Time Factors; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
[Clinical value of positron emission tomography (PET) in the diagnosis of bone and soft tissue tumors. 3rd Interdisciplinary Consensus Conference "PET in Oncology": results of the Bone and Soft Tissue Study Group].
Topics: Age Factors; Bone Neoplasms; Child; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Osteosarcoma; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
21 trial(s) available for fluorodeoxyglucose f18 and Sarcoma
| Article | Year |
|---|---|
Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea | 2022 |
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
18F-FES and 18F-FDG PET for differential diagnosis and quantitative evaluation of mesenchymal uterine tumors: correlation with immunohistochemical analysis.
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Glucose Transporter Type 1; Humans; Immunohistochemistry; Ki-67 Antigen; Leiomyoma; Middle Aged; Positron-Emission Tomography; Sarcoma; Uterine Neoplasms | 2013 |
Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Chemotherapy, Cancer, Regional Perfusion; Extremities; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Melphalan; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Tumor Necrosis Factor-alpha | 2014 |
Phase II study of cediranib in patients with advanced gastrointestinal stromal tumors or soft-tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents; Biomarkers; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Protein Kinase Inhibitors; Quinazolines; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Double autophagy modulators reduce 2-deoxyglucose uptake in sarcoma patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Blood Glucose; Drug Administration Schedule; Exanthema; Female; Fluorodeoxyglucose F18; Humans; Hydroxychloroquine; Male; Middle Aged; Nausea; Positron-Emission Tomography; Sarcoma; Sirolimus; Treatment Outcome; Tumor Burden; Young Adult | 2015 |
Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis.
Topics: Discriminant Analysis; Doxorubicin; Drug Therapy, Combination; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Patient Selection; Positron-Emission Tomography; Risk; Sarcoma; Survival Analysis; Treatment Outcome | 2010 |
Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Discriminant Analysis; Doxorubicin; Etoposide; Feasibility Studies; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ifosfamide; Neoadjuvant Therapy; Patient Selection; Radionuclide Imaging; Risk; Sarcoma; Time Factors; Treatment Outcome | 2010 |
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.
Topics: Adolescent; Biological Transport; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Neoadjuvant Therapy; Positron-Emission Tomography; Reference Standards; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden | 2010 |
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases".
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bronchoscopy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; International Agencies; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Neoplasms, Glandular and Epithelial; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Registries; Retrospective Studies; Sarcoma; Survival Rate; Time Factors; Tomography, X-Ray Computed; Young Adult | 2011 |
Additional value of 16α-[18F]fluoro-17β-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET.
Topics: Adult; Aged; Biological Transport; Diagnosis, Differential; Estradiol; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Middle Aged; Positron-Emission Tomography; Prospective Studies; Sarcoma; Uterine Neoplasms | 2011 |
Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Intraoperative; Positron-Emission Tomography; Predictive Value of Tests; Preoperative Care; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2011 |
PET-MR image fusion in soft tissue sarcoma: accuracy, reliability and practicality of interactive point-based and automated mutual information techniques.
Topics: Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Quality Control; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed | 2003 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting | 2003 |
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec).
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Male; Middle Aged; Piperazines; Prospective Studies; Pyrimidines; Radiopharmaceuticals; Sarcoma; Survival Analysis; Tomography, Emission-Computed; Treatment Failure | 2003 |
Can FDG PET be used to successfully direct preoperative biopsy of soft tissue tumours?
Topics: Adult; Aged; Algorithms; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Preoperative Care; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Subtraction Technique; Surgery, Computer-Assisted; Treatment Outcome | 2003 |
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Imatinib Mesylate; Middle Aged; Piperazines; Positron-Emission Tomography; Prognosis; Pyrimidines; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2004 |
Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Biomarkers; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 1; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sarcoma; Statistics as Topic | 2006 |
Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rhabdomyosarcoma; Sarcoma; Sarcoma, Ewing; Tomography, X-Ray Computed | 2007 |
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Treatment Outcome | 2008 |
Fluorodeoxyglucose PET in the evaluation of amputations for soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Amputation Stumps; Amputation, Surgical; Arm; Child; Female; Fluorodeoxyglucose F18; Humans; Leg; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Whole-Body Counting | 1999 |
225 other study(ies) available for fluorodeoxyglucose f18 and Sarcoma
| Article | Year |
|---|---|
Myofibrosarcoma infiltrating pulmonary arteries diagnosed on
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Retrospective Studies; Sarcoma | 2022 |
Paired 18F-Fluorodeoxyglucose (18F-FDG), and 64Cu-Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) (64Cu-ATSM) PET Scans in Dogs with Spontaneous Tumors and Evaluation for Hypoxia-Directed Therapy.
Topics: Animals; Clostridium; Coordination Complexes; Copper; Copper Radioisotopes; Diacetyl; Dogs; Fluorodeoxyglucose F18; Hypoxia; Organometallic Compounds; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thiosemicarbazones | 2022 |
What is the clinical impact of staging and surveillance PET-CT scan findings in patients with bone and soft tissue sarcoma?
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma | 2022 |
PET-CT staging affects time to treatment in sarcoma.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Time-to-Treatment | 2022 |
68 Ga-FAPI-04 Versus 18 F-FDG PET/CT in a Case With Intimal Sarcoma of the Pulmonary Artery.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Quinolines; Sarcoma; Soft Tissue Neoplasms | 2022 |
Prognostic value of fluorodeoxyglucose positron emission tomography derived metabolic parameters and textural features in pediatric sarcoma.
Topics: Adolescent; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma | 2022 |
FDG PET/CT in Metastatic Spindle Cell Sarcoma of Penile Origin: A Rare Malignancy.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Male; Penis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma | 2022 |
68 Ga-FAPI Versus 18 F-FDG PET/CT in Recurrent Undifferentiated Pleomorphic Sarcoma of Colon Mesentery.
Topics: Colon; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Mesentery; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Sarcoma | 2022 |
68 Ga-FAPI-04 PET/CT in Epithelioid Hemangioendothelioma With Pleura and Bone Metastases.
Topics: Adult; Aged; Bone Marrow Diseases; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Pleura; Positron Emission Tomography Computed Tomography; Quinolines; Sarcoma | 2022 |
PET/CT morphology and cardiac conduction disorders help discriminate primary cardiac lymphoma from primary cardiac sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Lymphoma; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Sarcoma | 2022 |
A Scoring System for Predicting Neoadjuvant Chemotherapy Response in Primary High-Grade Bone Sarcomas: A Multicenter Study.
Topics: Adolescent; Adult; Alkaline Phosphatase; Child; Child, Preschool; Cohort Studies; Fluorodeoxyglucose F18; Humans; Middle Aged; Necrosis; Neoadjuvant Therapy; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Treatment Outcome; Young Adult | 2022 |
Staging of newly diagnosed Ewing sarcoma: Results of bone marrow aspiration and biopsy versus (18)FDG-PET/CT imaging for bone marrow involvement.
Topics: Biopsy; Bone Marrow; Bone Marrow Neoplasms; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sarcoma, Ewing | 2023 |
Quality and consistency of clinical practice guideline recommendations for PET/CT and PET: a systematic appraisal.
Topics: Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2023 |
Right Adrenocortical Carcinoma Coexisting With Left Adrenal Sarcomatoid Carcinoma on FDG PET/CT.
Topics: Adrenal Cortex Neoplasms; Adrenal Glands; Adrenocortical Carcinoma; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoma; Soft Tissue Neoplasms | 2023 |
FDG PET/CT in a Case of Thoracic SMARCA4-Deficient Undifferentiated Tumor.
Topics: Biomarkers, Tumor; Diagnosis, Differential; DNA Helicases; Fluorodeoxyglucose F18; Humans; Nuclear Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoma; Transcription Factors | 2023 |
Radiation-Induced Sarcoma on 18F-FDG PET/CT After Treatment of Gorham-Stout Disease of the Maxilla.
Topics: Fluorodeoxyglucose F18; Humans; Male; Maxilla; Middle Aged; Neoplasms, Radiation-Induced; Osteolysis, Essential; Positron Emission Tomography Computed Tomography; Sarcoma | 2019 |
Pseudomyogenic Hemangioendothelioma: Distinctive FDG PET/CT Findings With Numerous Multilayer Lesions in a Single Distal Extremity.
Topics: Fluorodeoxyglucose F18; Hemangioendothelioma, Epithelioid; Humans; Lower Extremity; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Young Adult | 2020 |
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.
Topics: Biomarkers; Calibration; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Magnetic Resonance Imaging; Phantoms, Imaging; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Software; Tomography, X-Ray Computed | 2020 |
Right Atrial Intimal Sarcoma on 18F-FDG PET/CT.
Topics: Aged, 80 and over; Biological Transport; Echocardiography; Fluorodeoxyglucose F18; Heart Atria; Humans; Male; Positron Emission Tomography Computed Tomography; Sarcoma | 2020 |
Low-Grade Myofibroblastic Sarcoma Demonstrated on 99mTc-MDP Bone Scan and 18F-FDG PET/CT.
Topics: Bone and Bones; Female; Fluorodeoxyglucose F18; Humans; Myofibroblasts; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Sarcoma; Technetium Tc 99m Medronate; Young Adult | 2020 |
Fusion of FDG-PET Image and Clinical Features for Prediction of Lung Metastasis in Soft Tissue Sarcomas.
Topics: Adult; Aged; Computational Biology; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Lung Neoplasms; Male; Middle Aged; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2020 |
Intimal sarcoma of the pulmonary artery without
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Treatment Outcome; Tunica Intima; Vascular Neoplasms | 2020 |
Imaging of Soft Tissue Tumors.
Topics: Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2021 |
Differentiation of soft tissue and bone sarcomas from benign lesions utilizing
Topics: Adult; Aged; Bone Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; ROC Curve; Sarcoma; Soft Tissue Neoplasms; Tumor Burden | 2020 |
Primary Atrial Undifferentiated Sarcoma Found on FDG PET/CT Mimicking Cardiac Myxoma.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Atria; Heart Neoplasms; Humans; Male; Middle Aged; Myxoma; Positron Emission Tomography Computed Tomography; Sarcoma | 2020 |
Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on
Topics: Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Lymphoma, Large B-Cell, Diffuse; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma | 2021 |
Longitudinal observation of solitary fibrous tumor translation into malignant pulmonary artery intimal sarcoma.
Topics: Aged; Bone Neoplasms; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Sarcoma; Solitary Fibrous Tumors; Tunica Intima; Vascular Neoplasms | 2020 |
Clinical utilization of whole-body PET/MRI in childhood sarcoma.
Topics: Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2021 |
Pulmonary Artery Sarcoma With Low 18F-FDG Uptake.
Topics: Aged; Biological Transport; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Sarcoma; Vascular Neoplasms | 2021 |
Utility of 18F-FDG PET/CT in medical care of a promyelocytic sarcoma.
Topics: Fluorodeoxyglucose F18; Granulocyte Precursor Cells; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Positron Emission Tomography Computed Tomography; Sarcoma | 2021 |
Lung Adenocarcinoma Presenting as a Soft Tissue Metastasis to the Shoulder: A Case Report.
Topics: Adenocarcinoma of Lung; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Positron-Emission Tomography; Sarcoma; Shoulder | 2021 |
Primary pulmonary artery sarcoma concomitant with chronic thromboembolism: role of 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Thromboembolism | 2021 |
Role of
Topics: Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Retrospective Studies; Rhabdomyosarcoma; Sarcoma | 2021 |
Integrated 18F-FDG PET/MRI compared to MRI alone for identification of local recurrences of soft tissue sarcomas: a comparison trial.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2017 |
Multiparametric voxel-based analyses of standardized uptake values and apparent diffusion coefficients of soft-tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results.
Topics: Adult; Aged; Diffusion Magnetic Resonance Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tumor Burden | 2017 |
Unusual Presentation of Postradiation Sarcoma With Subsequent Intestinal Metastasis Revealed by 18F-FDG PET/CT.
Topics: Chemoradiotherapy; Fluorodeoxyglucose F18; Humans; Incidental Findings; Intestinal Neoplasms; Male; Middle Aged; Neoplasms, Radiation-Induced; Positron Emission Tomography Computed Tomography; Sarcoma | 2017 |
Efficacy of PET/CT to exclude leiomyoma in patients with lesions suspicious for uterine sarcoma on MRI.
Topics: Adult; Aged; Area Under Curve; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Leiomyoma; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Uterine Neoplasms | 2017 |
Soft Tissue Sarcoma Response to Two Cycles of Neoadjuvant Chemotherapy: A Multireader Analysis of MRI Findings and Agreement with RECIST Criteria and Change in SUVmax.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Observer Variation; Positron-Emission Tomography; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Treatment Outcome | 2018 |
Whole-body PET/MRI of Pediatric Patients: The Details That Matter.
Topics: Child; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tumor Stem Cell Assay; Whole Body Imaging | 2017 |
F-18 FDG PET/CT in pulmonary artery sarcoma: clinical vignette.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Sarcoma; Vascular Neoplasms | 2018 |
Significance of incidental intra-articular and peri-articular FDG avid foci on PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Incidental Findings; Joint Diseases; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Young Adult | 2019 |
Images in Vascular Medicine: Septic and tumor thrombosis caught by inferior vena cava filters and demonstrated on FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Neoplastic Cells, Circulating; Nose Neoplasms; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prosthesis Implantation; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Squamous Cell Carcinoma of Head and Neck; Vena Cava Filters; Venous Thrombosis | 2018 |
Is FDG-PET/CT Useful for Diagnosing Pulmonary Metastasis in Patients with Soft Tissue Sarcoma?
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed | 2018 |
Maxillofacial Spindle Cell Sarcoma With Lung Metastases on FDG PET/CT Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multiple Pulmonary Nodules; Positron Emission Tomography Computed Tomography; Sarcoma | 2018 |
Use of 18F-FDG-PET/CT for Retroperitoneal/Intra-Abdominal Soft Tissue Sarcomas.
Topics: Abdominal Cavity; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Positron Emission Tomography Computed Tomography; Prognosis; Retroperitoneal Neoplasms; Sarcoma; Sensitivity and Specificity | 2018 |
Probabilistic classification of tumour habitats in soft tissue sarcoma.
Topics: Aged; Aged, 80 and over; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Muscles; Necrosis; Positron-Emission Tomography; Probability; Sarcoma; Tumor Microenvironment | 2018 |
Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cell Proliferation; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Ki-67 Antigen; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; ROC Curve; Sarcoma; Survival Analysis; Time Factors; Young Adult | 2019 |
18F-FDG PET/CT in Isolated Primary Extraskeletal Osteosarcoma.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Osteosarcoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma | 2018 |
18F-FDG PET/CT Imaging in an Adolescent Patient With Primary Prostatic Stromal Sarcoma.
Topics: Adolescent; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sarcoma | 2019 |
A multiparametric MRI-based machine learning to distinguish between uterine sarcoma and benign leiomyoma: comparison with
Topics: Adult; Aged; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Leiomyoma; Machine Learning; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Uterine Neoplasms; Uterus; Young Adult | 2019 |
Thrombosed aneurysm of the ductus diverticulum mimicking malignancy on 18F-FDG PET/CT.
Topics: Aortic Aneurysm, Thoracic; Aortic Diseases; Diagnosis, Differential; Diverticulum; Ductus Arteriosus; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Thrombosis | 2018 |
Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients.
Topics: Adult; Aged; DNA Helicases; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Male; Middle Aged; Mutation; Neoplasm Invasiveness; Nuclear Proteins; Positron Emission Tomography Computed Tomography; Pulmonary Atelectasis; Radiopharmaceuticals; Sarcoma; Superior Vena Cava Syndrome; Thoracic Neoplasms; Tomography, X-Ray Computed; Transcription Factors; Tumor Burden; Young Adult | 2019 |
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas.
Topics: Adult; Aged; Angiogenesis Inhibitors; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Indazoles; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pyrimidines; Sarcoma; Sulfonamides; Treatment Outcome | 2019 |
The role of 18F-FDG PET/CT in soft tissue sarcoma.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sarcoma; Young Adult | 2019 |
Pulmonary artery intimal sarcoma: poor 18F-fluorodeoxyglucose uptake in positron emission computed tomography.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Tunica Intima; Vascular Neoplasms | 2013 |
Nodular fasciitis on (18)F-FDG PET.
Topics: Diagnosis, Differential; Fasciitis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Sarcoma | 2013 |
A rare case of primary pulmonary epithelioid angiosarcoma detected by (18)F-FDG PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Hemangiosarcoma; Humans; Lung Neoplasms; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2014 |
Necrosis on FDG PET/CT correlates with prognosis and mortality in sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Bone Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tomography, X-Ray Computed | 2013 |
Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Disease Progression; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Retrospective Studies; ROC Curve; Sarcoma; Tomography, X-Ray Computed; Young Adult | 2013 |
Imaging features of primary sarcomas of the great vessels in CT, MRI and PET/CT: a single-center experience.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy.
Topics: Fluorodeoxyglucose F18; Humans; Perfusion; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Image-Guided; Sarcoma | 2013 |
Chest wall sarcoma: 18F-FDG PET/CT in a patient with Li-Fraumeni syndrome.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Li-Fraumeni Syndrome; Positron-Emission Tomography; Sarcoma; Thoracic Wall; Tomography, X-Ray Computed | 2013 |
[Undifferentiated sarcoma: usefulness of multimodality cardiac imaging in characterizing a rare intracardiac mass].
Topics: Adult; Contrast Media; Echocardiography, Transesophageal; Fluorodeoxyglucose F18; Gadolinium DTPA; Heart Neoplasms; Humans; Magnetic Resonance Imaging, Cine; Male; Multimodal Imaging; Osteoarthropathy, Secondary Hypertrophic; Paraneoplastic Syndromes; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2013 |
Metabolic activity measured on PET/CT correlates with clinical outcomes in patients with limb and girdle sarcomas.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Disease-Free Survival; Extremities; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Sarcoma mid-therapy [F-18]fluorodeoxyglucose positron emission tomography (FDG PET) and patient outcome.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Monitoring, Physiologic; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Assessment; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Time Factors; Treatment Outcome; Young Adult | 2014 |
A case of pleural epithelioid sarcoma of proximal type presenting as malignant pleural mesothelioma.
Topics: Biomarkers, Tumor; Diagnosis, Differential; Fatal Outcome; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Pleural Neoplasms; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2013 |
Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1.
Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Child, Preschool; Demography; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2014 |
Prognostic value of 18F-FDG PET/CT in patients with soft tissue sarcoma: comparisons between metabolic parameters.
Topics: Adult; Biomarkers, Tumor; Female; Fluorodeoxyglucose F18; Humans; Incidence; Male; Middle Aged; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Republic of Korea; Sarcoma; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Paget sarcoma of the pelvic bone with widespread metastatic disease on radiography, CT, MRI, and 18F-FDG PET/CT with pathologic correlation.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Metastasis; Osteitis Deformans; Pelvic Bones; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2014 |
Relative role of motion and PSF compensation in whole-body oncologic PET-MR imaging.
Topics: Aged; Algorithms; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Movement; Multimodal Imaging; Phantoms, Imaging; Positron-Emission Tomography; Respiration; Sarcoma; Whole Body Imaging | 2014 |
Multiple cardiac masses and distant metastatic foci in a patient with high grade pleomorphic sarcoma of the heart revealed by follow-up FDG PET/CT.
Topics: Adult; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Neoplasms; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasms, Multiple Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2014 |
Malignant peritoneal mesothelioma with lower extremity metastasis: PET/CT imaging.
Topics: Aged; Female; Femoral Neoplasms; Fluorodeoxyglucose F18; Humans; Lower Extremity; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Multimodal Imaging; Neoplasms, Second Primary; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Metastatic undifferentiated spindle cell sarcoma of the thyroid gland evaluated by 18F-FDG PET/CT.
Topics: Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thyroid Neoplasms; Tomography, X-Ray Computed | 2015 |
Nodular fasciitis mimicking soft tissue metastasis on 18F-FDG PET/CT during surveillance.
Topics: Adult; Diagnosis, Differential; Fasciitis; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2015 |
Chronic expanding hematoma with a significantly high fluorodeoxyglucose uptake on ¹⁸F-fluorodeoxyglucose positron emission tomography, mimicking a malignant soft tissue tumor: a case report.
Topics: Adult; Biopsy; Diagnosis, Differential; Fluorodeoxyglucose F18; Hematoma; Humans; Leg; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2014 |
Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma.
Topics: Adolescent; Adult; Child; Child, Preschool; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Humans; Infant; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Whole Body Imaging; Young Adult | 2015 |
Abdominal Wall Desmoid Fibromatosis Mimics Sarcoma With Intense FDG Uptake on FDG PET/CT.
Topics: Abdominal Wall; Diagnostic Errors; Fibromatosis, Aggressive; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2015 |
Evaluation of several FDG PET parameters for prediction of soft tissue tumour grade at primary diagnosis and recurrence.
Topics: Female; Fluorodeoxyglucose F18; Humans; Liver; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2015 |
Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial.
Topics: Clinical Trials, Phase III as Topic; Fluorodeoxyglucose F18; Guidelines as Topic; Humans; Multicenter Studies as Topic; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Sarcoma; Soft Tissue Neoplasms | 2015 |
Combined 18F-NaF and 18F-FDG PET/CT in the Evaluation of Sarcoma Patients.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Sodium Fluoride; Tomography, X-Ray Computed | 2015 |
A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Extremities; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2015 |
Semi-Quantitative Calculations of Primary Tumor Metabolic Activity Using F-18 FDG PET/CT as a Predictor of Survival in 92 Patients With High-Grade Bone or Soft Tissue Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Denmark; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Radionuclide Imaging; Retrospective Studies; ROC Curve; Sarcoma; Soft Tissue Neoplasms; Young Adult | 2015 |
Pulmonary Artery Sarcoma Detected on 18F-FDG PET/CT With Unusual Findings.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2015 |
Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis.
Topics: Animals; Cell Proliferation; Copper Radioisotopes; Dogs; Fluorodeoxyglucose F18; Glycolysis; Hypoxia; Positron-Emission Tomography; Sarcoma | 2015 |
Synergistic role of simultaneous PET/MRI-MRS in soft tissue sarcoma metabolism imaging.
Topics: Chemotherapy, Adjuvant; False Positive Reactions; Female; Fluorodeoxyglucose F18; Glucose; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Sarcoma; Treatment Outcome | 2016 |
Metastatic Malignant Fibrous Histiocytoma Infiltrating Sigmoid Colon: A Case Diagnosed With the Help of 18F-FDG PET/CT.
Topics: Colon, Sigmoid; Female; Fluorodeoxyglucose F18; Histiocytoma, Malignant Fibrous; Humans; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2016 |
Volume-Based F-18 FDG PET/CT Imaging Markers Provide Supplemental Prognostic Information to Histologic Grading in Patients With High-Grade Bone or Soft Tissue Sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Tumor Burden; Young Adult | 2015 |
Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.
Topics: Aged; C-Reactive Protein; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Mutation; Polymerase Chain Reaction; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2016 |
Dual-time point 18FDG-PET/CT imaging may be useful in assessing local recurrent disease in high grade bone and soft tissue sarcoma.
Topics: Adult; Aged; Bone Neoplasms; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed | 2016 |
Metabolic Tumour Burden Measured by 18F-FDG PET/CT Predicts Malignant Transformation in Patients with Neurofibromatosis Type-1.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 1; Prognosis; Radionuclide Imaging; Retrospective Studies; Sarcoma; Survival Rate; Tumor Burden; Young Adult | 2016 |
Focal Inflammatory Myositis on 18F-FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Myositis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma | 2016 |
Right Ventricle Metastasis of Pleomorfic Undifferentiated Sarcoma Detected by FDG PET/CT and Three-Dimensional Echocardiography.
Topics: Aged; Diagnosis, Differential; Echocardiography, Three-Dimensional; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Ventricles; Humans; Male; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma | 2016 |
Primary Pulmonary Artery Sarcoma on Dual-Time Point FDG PET/CT Imaging.
Topics: Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Vascular Neoplasms | 2016 |
Appropriate margin thresholds for isocontour metabolic volumetry of fluorine-18 fluorodeoxyglucose PET in sarcoma: a hybrid PET/MRI study.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Tumor Burden | 2016 |
[Is FDG TEP CT practice changing in the management of sarcomas in adults?].
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity | 2016 |
Detection of a primary tumor in the area of the renal artery with 18F-FDG PET/CT in a patient with metastatic undifferentiated sarcoma and a history of mid-aortic syndrome: A case report.
Topics: Aortic Diseases; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Pelvic Bones; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Renal Artery; Sarcoma; Vascular Neoplasms | 2016 |
Detection of lymph node metastases in pediatric and adolescent/young adult sarcoma: Sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging-A prospective trial.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymph Node Excision; Lymphatic Metastasis; Lymphoscintigraphy; Male; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Sentinel Lymph Node; Sentinel Lymph Node Biopsy; Tomography, X-Ray Computed; Young Adult | 2017 |
Re: FDG PET/CT Findings of Intracardiac Myeloid Sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Sarcoma, Myeloid; Tomography, X-Ray Computed | 2017 |
Metastatic epithelioid sarcoma revealed with
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Muscle Neoplasms; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Wrist | 2016 |
Statistical assessment of treatment response in a cancer patient based on pre-therapy and post-therapy FDG-PET scans.
Topics: Antineoplastic Agents; Confidence Intervals; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Linear Models; Models, Statistical; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Reproducibility of Results; Sarcoma; Treatment Outcome | 2017 |
Spindle Cell Sarcoma of the Iliac Vein on 18 F-FDG PET/CT.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Iliac Vein; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2017 |
18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma.
Topics: Estradiol; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Survival Rate; Uterine Neoplasms | 2017 |
Intensity of FDG uptake is not everything: synchronous liposarcoma and fibrous dysplasia in the same patient on FDG PET-CT imaging.
Topics: Diagnostic Imaging; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liposarcoma; Male; Middle Aged; Neoplasms, Second Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Whole Body Imaging | 2008 |
F-18 fluorodeoxyglucose (FDG) PET in the diagnosis of malignant transformation of fibrous dysplasia in the pelvic bones.
Topics: Bone and Bones; Cell Proliferation; Cell Transformation, Neoplastic; Fatal Outcome; Female; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Metastasis; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2008 |
Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Uterine Neoplasms; Whole Body Imaging | 2008 |
Epithelioid sarcoma with muscle metastasis detected by positron emission tomography.
Topics: Adult; Biopsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Muscle Neoplasms; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2008 |
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Outcome Assessment, Health Care; Prevalence; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sarcoma; Sensitivity and Specificity; Survival Analysis; Survival Rate; United States | 2008 |
Occult myofibroblastic sarcoma detected on FDG-PET performed for cancer screening.
Topics: Female; Fluorodeoxyglucose F18; Humans; Mass Screening; Middle Aged; Muscle Neoplasms; Neoplasms, Unknown Primary; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2008 |
Thromboembolism in pulmonary artery sarcoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Sarcoma; Thromboembolism; Tomography, X-Ray Computed; Vascular Neoplasms | 2009 |
Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
Topics: Animals; Autoradiography; Cell Line, Tumor; Diagnosis, Differential; Disease Models, Animal; Fluoroacetates; Fluorodeoxyglucose F18; Inflammation; Male; Mice; Misonidazole; Positron-Emission Tomography; Radioactive Tracers; Sarcoma; Tissue Distribution | 2009 |
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Deoxycytidine; Doxorubicin; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Gemcitabine; Humans; Ifosfamide; Male; Middle Aged; Neoadjuvant Therapy; Positron-Emission Tomography; Prospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
F-18 FDG PET/CT findings in a case of undifferentiated embryonal sarcoma of the liver with lung and adrenal gland metastasis in a child.
Topics: Adrenal Gland Neoplasms; Child; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2009 |
Impact of PET and CT in PET/CT studies for staging and evaluating treatment response in bone and soft tissue sarcomas.
Topics: Bone Neoplasms; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sarcoma; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
PET/CT for radiotherapy treatment planning in patients with soft tissue sarcomas.
Topics: Fluorodeoxyglucose F18; Humans; Leg; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Tumor Burden | 2009 |
Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas.
Topics: Adolescent; Adult; Cell Transformation, Neoplastic; Exostoses; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Osteochondroma; Pelvic Pain; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2009 |
Avid F-18 FDG uptake in prostatic sarcoma.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Prostatic Neoplasms; Radionuclide Imaging; Sarcoma; Whole Body Imaging | 2009 |
FDG PET/CT imaging in primary osseous and soft tissue sarcomas: a retrospective review of 212 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Child; Child, Preschool; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Young Adult | 2009 |
Diagnostic usefulness of 18F-FDG PET/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism.
Topics: Adult; Aged, 80 and over; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Sarcoma; Tomography, X-Ray Computed | 2009 |
F-18 FDG PET-CT imaging in gastric sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed; Young Adult | 2009 |
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Remission Induction; Sarcoma; Soft Tissue Neoplasms; Treatment Outcome; Young Adult | 2009 |
Contemporary imaging in sarcoma.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2009 |
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dioxoles; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome | 2009 |
Intense accumulation of 18F-FDG, not enhancement on MRI, helps to guide the surgical biopsy accurately in soft tissue tumors.
Topics: Biopsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms | 2009 |
Spindle cell sarcoma degeneration of giant cell tumor of the knee, imaged with F-18 FDG PET-CT and Tc-99m MDP bone scan.
Topics: Bone and Bones; Disease Progression; Fluorodeoxyglucose F18; Giant Cell Tumor of Bone; Humans; Knee; Male; Middle Aged; Positron-Emission Tomography; Sarcoma; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2010 |
FDG-PET in diagnostic work-up of pulmonary artery sarcomas.
Topics: Adult; Aged; Chronic Disease; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Sarcoma; Thromboembolism; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas.
Topics: Excitatory Amino Acid Transporter 2; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Immunohistochemistry; L-Lactate Dehydrogenase; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Uterine Neoplasms | 2010 |
[Combined functional and morphological imaging of sarcomas: significance for diagnostics and therapy monitoring].
Topics: Adult; Fluorodeoxyglucose F18; Germany; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
The significance of size change of soft tissue sarcoma during preoperative radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Dose Fractionation, Radiation; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy, Adjuvant; Sarcoma; Survival Analysis; Thallium Radioisotopes; Treatment Outcome; Victoria | 2010 |
Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glycolysis; Humans; Male; Middle Aged; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Young Adult | 2010 |
Multiple FDG-avid sclerosing hemangiomas mimicking pulmonary metastases in a case of soft tissue sarcoma.
Topics: Adult; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2010 |
Case 166: Metastatic left pulmonary artery sarcoma.
Topics: Colorectal Neoplasms; Fluorodeoxyglucose F18; Humans; Iohexol; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Vascular Neoplasms | 2011 |
Bone infarct-associated sarcoma detected on FDG PET/CT.
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2011 |
PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremities.
Topics: Adolescent; Adult; Aged; Blood Circulation; Bone Neoplasms; Extremities; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Oxygen Radioisotopes; Positron-Emission Tomography; Sarcoma; Treatment Outcome; Water | 2011 |
Multiagent PET for risk characterization in sarcoma.
Topics: Carbon Dioxide; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Isotope Labeling; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Sarcoma; Thymidine; Verapamil | 2011 |
Novel human single chain antibody fragments that are rapidly internalizing effectively target epithelioid and sarcomatoid mesotheliomas.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Immunotoxins; Isotope Labeling; Male; Mesothelioma; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Single-Chain Antibodies; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2011 |
Images in vascular medicine . Metastatic aortic intimal sarcoma: the use of PET/CT in diagnosing and staging.
Topics: Aged; Angiography; Aorta, Thoracic; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Tunica Intima; Vascular Neoplasms | 2011 |
Pulmonary artery intimal sarcoma: the role of ¹⁸F-fluorodeoxyglucose positron emission tomography in monitoring response to treatment.
Topics: Biopsy, Fine-Needle; Combined Modality Therapy; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Tunica Intima; Vascular Neoplasms | 2011 |
F-18 FDG PET/CT as a crucial guide toward optimal treatment planning in a case of postirradiation sarcoma 10 years after primary bone lymphoma of the pelvis.
Topics: Adult; Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Lymphoma; Magnetic Resonance Imaging; Male; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed | 2011 |
Pulmonary artery sarcoma detected on F-18 FDG PET/CT as origin of multiple spinal metastases.
Topics: Aged; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Pulmonary Artery; Sarcoma; Spinal Neoplasms; Tomography, X-Ray Computed; Vascular Neoplasms | 2011 |
A statistical modeling approach to the analysis of spatial patterns of FDG-PET uptake in human sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Models, Biological; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Regression Analysis; Sarcoma | 2011 |
Sarcomatoid hepatocellular carcinoma diagnosed by FDG PET/CT.
Topics: Aged; Carcinoma, Hepatocellular; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Tomography, X-Ray Computed; Ultrasonography | 2011 |
18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
Topics: Adolescent; Biomarkers, Tumor; Bone Neoplasms; Cell Proliferation; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Infant; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2011 |
Radiation-associated head and neck sarcomas: spectrum of imaging findings.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2012 |
3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Humans; Ki-67 Antigen; Male; Middle Aged; Multimodal Imaging; Neoadjuvant Therapy; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thymidine Kinase; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Imaging in sarcoma.
Topics: Fluorodeoxyglucose F18; Humans; Neoplasm Staging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Treatment Outcome | 2011 |
Role of FDG PET-CT in detecting recurrence in patients with uterine sarcoma: comparison with conventional imaging.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Uterine Neoplasms | 2012 |
EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Biopsy, Fine-Needle; Diagnosis, Differential; Dyspnea; Female; Fluorodeoxyglucose F18; Humans; Hypertension; Lung Neoplasms; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiography, Thoracic; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography; Vascular Neoplasms; Warfarin | 2011 |
Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients?
Topics: Adolescent; Bone Neoplasms; Child; Child, Preschool; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Multimodal Imaging; Positron-Emission Tomography; Radionuclide Imaging; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Technetium Tc 99m Medronate; Tomography, X-Ray Computed | 2012 |
Value of PET scan in patients with retroperitoneal sarcoma treated with preoperative radiotherapy.
Topics: Adult; Aged; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Laparotomy; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Postoperative Care; Preoperative Care; Prognosis; Radiotherapy, Adjuvant; Reproducibility of Results; Retrospective Studies; Risk Assessment; Sarcoma; Survival Analysis; Treatment Outcome | 2012 |
18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Multivariate Analysis; Neoadjuvant Therapy; Outcome Assessment, Health Care; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Time Factors; Tomography, X-Ray Computed; Young Adult | 2012 |
Malignant transformation of retroperitoneal inflammatory pseudotumor to undifferentiated high-grade pleomorphic sarcoma on FDG PET/CT.
Topics: Aged; Cell Differentiation; Cell Transformation, Neoplastic; Female; Fluorodeoxyglucose F18; Granuloma, Plasma Cell; Humans; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Retroperitoneal Neoplasms; Sarcoma; Tomography, X-Ray Computed | 2012 |
Correlating metabolic activity on 18F-FDG PET/CT with histopathologic characteristics of osseous and soft-tissue sarcomas: a retrospective review of 136 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Neoplasm Staging; Osteosarcoma; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Statistics, Nonparametric; Tomography, X-Ray Computed | 2012 |
The diagnostic and prognostic value of ¹⁸F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients.
Topics: Adolescent; Adult; Aged; Biological Transport; Bone Neoplasms; Child; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Grading; Positron-Emission Tomography; Prognosis; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Young Adult | 2012 |
(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry.
Topics: Animals; Autoradiography; Carcinoma; Cell Hypoxia; Coordination Complexes; Copper Radioisotopes; Dogs; Fluorodeoxyglucose F18; Immunohistochemistry; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Thiosemicarbazones | 2012 |
Prediction of treatment outcomes in patients with chest wall sarcoma: evaluation with PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Survival Rate; Thoracic Neoplasms; Thoracic Wall; Tomography, X-Ray Computed; Young Adult | 2012 |
Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism.
Topics: Adult; Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sarcoma; Tomography, X-Ray Computed; Vascular Neoplasms | 2013 |
[Positron emission tomography-computed tomography in tumors of the locomotor apparatus].
Topics: Bone Neoplasms; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Muscle Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2012 |
A retrospective study comparing contrast-enhanced computed tomography with 18F-FDG-PET/CT in the early follow-up of patients with retroperitoneal sarcomas.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Recurrence; Retroperitoneal Neoplasms; Retrospective Studies; Sarcoma; Time Factors; Tomography, X-Ray Computed | 2013 |
Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2013 |
(18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2013 |
Proximal-type epithelioid sarcoma of the scrotum: 18F-FDG PET/CT imaging.
Topics: Adult; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Sarcoma; Scrotum; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2013 |
Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Bone Neoplasms; Disease Progression; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prognosis; Regression Analysis; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Tissue Distribution; Tomography, Emission-Computed; Treatment Outcome | 2002 |
Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2002 |
FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Transitional Cell; Catheter Ablation; Colonic Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Pancreatic Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome; Whole-Body Counting | 2003 |
Comparison of MR and PET imaging for the evaluation of liver metastases.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
FDG PET imaging guided re-evaluation of histopathologic response in a patient with high-grade sarcoma.
Topics: Chemotherapy, Adjuvant; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Thigh; Tomography, Emission-Computed | 2003 |
18FDG PET scanning of benign and malignant musculoskeletal lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2003 |
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Carcinoma; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Mesothelioma; Middle Aged; Neoplasm Staging; New York; Pleural Neoplasms; Predictive Value of Tests; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Statistics as Topic; Thoracic Cavity; Thoracic Surgical Procedures; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Diagnosis of labia metastasis by F-18 FDG PET and CT fusion imaging in sarcoma follow-up.
Topics: Adult; Diagnosis, Differential; Diagnostic Errors; Extravasation of Diagnostic and Therapeutic Materials; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Pelvic Neoplasms; Predictive Value of Tests; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma; Subtraction Technique; Vulvar Neoplasms | 2003 |
A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data.
Topics: Algorithms; Fluorodeoxyglucose F18; Humans; Prognosis; Proportional Hazards Models; Risk Factors; Sarcoma; Statistics as Topic; Survival Analysis; Tomography, Emission-Computed | 2003 |
[18F]5-fluoro-2-deoxyuridine-PET for imaging of malignant tumors and for measuring tissue proliferation.
Topics: Adult; Aged; Bone and Bones; Cell Division; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ki-67 Antigen; Kidney; Liver; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Neoplasms; Prospective Studies; Radiopharmaceuticals; Sarcoma; Tissue Distribution; Tomography, Emission-Computed; Urinary Bladder | 2003 |
Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local recurrent and distant metastatic sarcoma.
Topics: Adolescent; Adult; Aged; Child; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[Biologic characterization of soft tissue sarcomes by positron emission tomography (initial results)].
Topics: Amino Acid Transport System A; Aminoisobutyric Acids; Blood Glucose; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Neoplasm Proteins; Oxygen Radioisotopes; Regional Blood Flow; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1998 |
F-18 FDG positron emission tomography imaging of rare soft tissue sarcomas: low-grade fibromyxoid sarcoma and malignant hemangiopericytoma.
Topics: Female; Fibroma; Fluorodeoxyglucose F18; Hemangiopericytoma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Rare Diseases; Sarcoma | 2004 |
Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
Topics: Adolescent; Adult; Aged; Chemotherapy, Adjuvant; Child; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lower Extremity; Male; Middle Aged; Multivariate Analysis; Neoadjuvant Therapy; Neoplasm Staging; Orthopedic Procedures; Positron-Emission Tomography; Probability; Prospective Studies; Risk Assessment; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Upper Extremity | 2005 |
Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms | 2005 |
Fluorodeoxyglucose positron emission tomography scanning: basic principles and imaging of adult soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Proportional Hazards Models; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Treatment Outcome | 2004 |
FDG-PET/CT findings of sarcomatous transformation in neurofibromatosis: a case report.
Topics: Adult; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Male; Neurofibromatoses; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Subtraction Technique; Tomography, X-Ray Computed | 2005 |
Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET.
Topics: Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Models, Biological; Positron-Emission Tomography; Predictive Value of Tests; Sarcoma; Survival Analysis | 2005 |
Images in cardiovascular medicine. Cardiac transplantation for giant sarcoma of the left ventricle.
Topics: Child; Fluorodeoxyglucose F18; Heart Neoplasms; Heart Transplantation; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2005 |
PET/CT with diagnostic CT in the evaluation of childhood sarcoma.
Topics: Child; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2006 |
PET-positive fibrous dysplasia--a potentially misleading incidental finding in a patient with intimal sarcoma of the pulmonary artery.
Topics: Adult; Contrast Media; Diagnosis, Differential; Fibrous Dysplasia of Bone; Fluorodeoxyglucose F18; Humans; Incidental Findings; Magnetic Resonance Imaging; Male; Pneumonectomy; Pulmonary Artery; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed; Tunica Intima; Vascular Neoplasms | 2007 |
Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: a case study and review of the literature.
Topics: Adult; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2006 |
Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis.
Topics: Adult; Breast Neoplasms; Cervical Vertebrae; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery; Radiotherapy Planning, Computer-Assisted; Sarcoma; Spinal Neoplasms; Thoracic Vertebrae | 2006 |
18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Muscle Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography; Radiography, Thoracic; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed | 2006 |
Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Topics: Carcinoma, Renal Cell; Fluorodeoxyglucose F18; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2006 |
PET/CT in paediatrics: it is time to increase its use!
Topics: Biopsy; Child; Diagnostic Imaging; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Pediatrics; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Topics: Adolescent; Adult; Bone Neoplasms; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Recurrence; Retrospective Studies; Sarcoma; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
18F-fluorodeoxythymidine PET for evaluating the response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcomas.
Topics: Adult; Aged; Dideoxynucleosides; Extremities; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypothermia, Induced; Male; Middle Aged; Positron-Emission Tomography; Sarcoma | 2007 |
Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease.
Topics: Fluorodeoxyglucose F18; Humans; Neurofibromatosis 1; Positron-Emission Tomography; Sarcoma | 2007 |
Pulmonary artery sarcoma mimicking pulmonary thromboembolism: integrated FDG PET/CT.
Topics: Adult; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Pulmonary Artery; Pulmonary Embolism; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed; Vascular Neoplasms | 2007 |
Preoperative imaging for metastasectomy.
Topics: Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma; Colorectal Neoplasms; Contrast Media; Diagnostic Imaging; Digestive System Neoplasms; Enteroendocrine Cells; Fluorodeoxyglucose F18; Humans; Intraoperative Care; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
Accuracy of 18F fluorodeoxyglucose positron emission tomography/computed tomography in staging of pediatric sarcomas.
Topics: Adolescent; Child; Child, Preschool; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2007 |
[Utility of 18 FDG positon emission tomography in detection of sarcomatous transformation in neurofibromatosis type 1].
Topics: Adolescent; Adult; Aged; Cell Transformation, Neoplastic; Child; Decision Trees; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibromatosis 1; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma | 2007 |
Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Preoperative Care; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, X-Ray Computed | 2007 |
FDG PET/CT findings of epithelioid sarcoma in a pediatric patient.
Topics: Child; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Pleural Effusion; Positron-Emission Tomography; Sacrum; Sarcoma; Tomography, X-Ray Computed | 2007 |
F-18 FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Ifosfamide; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2008 |
Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma; Tomography, X-Ray Computed | 2008 |
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma.
Topics: Deoxyglucose; Diagnosis, Differential; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
FDG-PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Cancer, Regional Perfusion; Deoxyglucose; Extremities; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Interferon-gamma; Male; Melphalan; Middle Aged; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Necrosis Factor-alpha | 1996 |
FDG-PET screening for cerebral metastases in patients with suspected malignancy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Breast Neoplasms; Child; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphoma; Male; Melanoma; Middle Aged; Retrospective Studies; Sarcoma; Testicular Neoplasms; Tomography, Emission-Computed | 1996 |
Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hyperthermia, Induced; Male; Middle Aged; Muscle Neoplasms; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1996 |
Comparison of fluorine-18-FDG PET and technetium-99m-MIBI SPECT in evaluation of musculoskeletal sarcomas.
Topics: Adult; Bone Neoplasms; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Neoplasm, Residual; Sarcoma; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Detection of local recurrence of soft-tissue sarcoma with positron emission tomography using [18F]fluorodeoxyglucose.
Topics: Adult; Aged; Aged, 80 and over; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Reproducibility of Results; Sarcoma; Sensitivity and Specificity; Statistics, Nonparametric; Tomography, Emission-Computed | 1997 |
Tumor metabolic rates in sarcoma using FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Middle Aged; Sarcoma; Tomography, Emission-Computed | 1998 |
Quantitative [F-18]fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Fluorodeoxyglucose F18; Humans; Middle Aged; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 1998 |
Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Evaluation Studies as Topic; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole-Body Counting | 1998 |
F-18 FDG whole-body positron emission tomography scan in primary breast sarcoma.
Topics: Adolescent; Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Phyllodes Tumor; Radiopharmaceuticals; Rhabdomyosarcoma, Alveolar; Sarcoma; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1998 |
Carbon-11-thymidine and FDG to measure therapy response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon Radioisotopes; Carcinoma, Small Cell; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Thymidine; Tomography, Emission-Computed | 1998 |
A PET study of 18FDG uptake in soft tissue masses.
Topics: Case-Control Studies; Connective Tissue Diseases; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Time Factors; Tomography, Emission-Computed | 1999 |
Prospective evaluation of soft tissue masses and sarcomas using fluorodeoxyglucose positron emission tomography.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Metastasis; Prospective Studies; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 1999 |
Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
Topics: Adolescent; Adult; Aged; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Radiopharmaceuticals; Sarcoma; Soft Tissue Neoplasms; Statistics, Nonparametric; Tomography, Emission-Computed | 2000 |
F-18 fluorodeoxyglucose positron emission tomographic imaging: in search of an unknown primary tumor.
Topics: Adult; Female; Fluorodeoxyglucose F18; Hand; Humans; Neoplasms, Unknown Primary; Radiopharmaceuticals; Reflex Sympathetic Dystrophy; Sarcoma; Tomography, Emission-Computed | 2000 |
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma.
Topics: Adult; Aged; Bone Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Data Interpretation, Statistical; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Ki-67 Antigen; Middle Aged; Neoplasm Staging; Nuclear Proteins; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-mdm2; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed; Tumor Suppressor Protein p53 | 2000 |
Positron emission tomography and the orthopaedic surgeon.
Topics: Bone Neoplasms; Contrast Media; Fluorodeoxyglucose F18; Humans; Osteosarcoma; Prognosis; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2000 |
Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Female; Fluorodeoxyglucose F18; Glucose-6-Phosphate Isomerase; Humans; Male; Middle Aged; Musculoskeletal Diseases; Radionuclide Imaging; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms | 2000 |
Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET.
Topics: Adult; Bone and Bones; Bone Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed | 2000 |
Role of repeated F-18 fluorodeoxyglucose imaging in management of patients with bone and soft tissue sarcoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Posture; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
Topics: Antineoplastic Agents; Benzamides; Enzyme Inhibitors; Female; Fluorodeoxyglucose F18; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Sarcoma; Stomach Neoplasms; Stromal Cells; Tomography, Emission-Computed | 2001 |
Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading.
Topics: Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Soft Tissue Neoplasms; Tomography, Emission-Computed | 2001 |
Detection of isolated distant metastasis in soft tissue sarcoma by fluorodeoxyglucose positron emission tomography: case report.
Topics: Adolescent; Arm; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Hand; Humans; Radionuclide Imaging; Rhabdomyosarcoma, Embryonal; Sarcoma | 2001 |
F-18 fluorodeoxyglucose positron emission tomography in mesenterial Castleman's lymphoma.
Topics: Castleman Disease; Diagnostic Errors; Female; Fluorodeoxyglucose F18; Humans; Mesentery; Middle Aged; Peritoneal Neoplasms; Radiopharmaceuticals; Sarcoma; Tomography, Emission-Computed | 2001 |
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed | 2002 |
FDG positron emission tomographic imaging of pseudo-pseudo tumor.
Topics: Aged; Aged, 80 and over; Biopsy, Needle; Diagnosis, Differential; Dyspnea; False Positive Reactions; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Plasma Cell Granuloma, Pulmonary; Pulmonary Disease, Chronic Obstructive; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sarcoma | 2002 |